These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
The purpose of this study is to evaluate long-term safety of subcutaneous guselkumab in pediatric participants with moderately to severely active ulcerative…
This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration…
The study will aim to estimate the efficacy of apremilast compared with placebo in the treatment of juvenile psoriatic arthritis (JPsA) in…
This study is an international, single arm, multicenter, prospective, non-significant risk, Post-Market Clinical Follow-up study, which is designed to collect safety and…
This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to…
This is a study to confirm the clinical efficacy and safety of sonelokimab compared with placebo in the treatment of adults with…
Your patient insight is valuable. Take a short survey and help researchers improve treatments for Bones & Joints.
Living with Bones & Joints? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Bones & Joints. Connect, share experiences, and support each other.
No podcasts available yet for Bones & Joints
Sign up for updates below to be notified when we release a free patient podcast for this area.